Neurodegenerative Disease Market Strengthens as Biopharma Investments Rise Worldwide
The global neurodegenerative disease market is poised for robust growth over the next decade, with the industry expected to expand from an estimated USD 55.6 billion in 2025 to USD 109.5 billion by 2035. This marks a compound annual growth rate (CAGR) of 6.9%, underscoring the immense opportunities available for manufacturers in this rapidly evolving sector. The growth is primarily driven by the increasing prevalence of neurological disorders, such as Alzheimer’s, Parkinson’s, and Huntington’s diseases, alongside advancements in drug development and research. Get a Sample Report:- https://www.futuremarketinsights.com/reports/sample/rep-gb-1052 Escalating Demand for Neurodegenerative Disease Therapies Neurodegenerative diseases are a growing concern globally, with the aging population contributing significantly to the rise in incidence rates. As life expectancy increases, so does the prevalence of conditions like Alzheimer's and Parkinson’s disease, which has r...